Back to Search
Start Over
[Adaptation and validation of a brief screening questionnaire of depressive disorders in patients with cancer: Q2i study].
- Source :
-
Bulletin du cancer [Bull Cancer] 2016 Feb; Vol. 103 (2), pp. 138-47. Date of Electronic Publication: 2015 Oct 23. - Publication Year :
- 2016
-
Abstract
- Background: Depression is a sustainable state of deep sadness and abatement. It is frequently identified in patients with cancer and often undervalued by oncologists. The reduced PRIME-MD questionnaire is a questionnaire of 2 items validated in French. However, it has been neither translated nor validated in French. The objective of our study is to translate the PRIME-MD and validate it into French.<br />Method: The PRIME-MD questionnaire was translated into French by using the recommendations of the EORTC and compared to the French gold standard questionnaire Mini-International Neuropsychiatric Interview (MINI).<br />Results: Two hundred and ninety-nine patients were included in our study. With a 98% filling rate, the Q2i questionnaire has been well accepted. The prevalence of depression in our population was measured at 7.4%. With a sensitivity of 89.47%, a specificity of 58.85%, found percentages are equal to those of the questionnaire in English. The negative predictive value was measured at 98.52%.<br />Conclusion: This study demonstrates that the Q2i questionnaire is a quick and easy screening tool, requiring less than 2minutes to target patients likely to benefit from psychological support.<br /> (Copyright © 2015 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)
Details
- Language :
- French
- ISSN :
- 1769-6917
- Volume :
- 103
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Bulletin du cancer
- Publication Type :
- Academic Journal
- Accession number :
- 26602270
- Full Text :
- https://doi.org/10.1016/j.bulcan.2015.09.008